The gut microbiota in immune-mediated inflammatory diseases

Frontiers in Microbiology

Volumn 7, Issue JUL, 2016, Pages

  Forbes, Jessica D ^a,b   Van Domselaar, Gary ^a,b   Bernstein, Charles N ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b PUBLIC HEALTH AGENCY OF CANADA   (Canada)

Author keywords

Chronic immune mediated inflammatory diseases; Dysbiosis; Metagenome; Microbiome; Systems microbiology

Indexed keywords

MACROLIDE; NITROIMIDAZOLE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAXIMIN;

ALLERGIC ENCEPHALOMYELITIS; ANKYLOSING SPONDYLITIS; CLOSTRIDIUM; DYSBIOSIS; FUSOBACTERIUM; GENETIC SUSCEPTIBILITY; GENOTYPE PHENOTYPE CORRELATION; HUMAN; IMMUNE SYSTEM; INFLAMMATION; INFLAMMATORY BOWEL DISEASE; INFLAMMATORY DISEASE; INTESTINE FLORA; KNOWLEDGE; MICROBIOLOGY; MULTIPLE SCLEROSIS; NONHUMAN; PSORIASIS; PSORIATIC ARTHRITIS; REVIEW; RHEUMATOID ARTHRITIS; RISK FACTOR; SPONDYLOARTHROPATHY; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 84983084769     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2016.01081     Document Type: Review

References (185)

1. Abbott, A. (2016). Scientists bust myth that our bodies have more bacteria than human cells. Nature doi: 10.1038/nature.2016.19136
2. Abdollahi-Roodsaz, S., Joosten, L. A. B., Koenders, M. I., Devesa, I., Roelofs, M. F., Radstake, T. R., et al. (2008). Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis. J. Clin. Invest. 118, 205-216. doi: 10.1172/JCI32639
3. Adams, L. A., and Morrison, M. (2016). The microbiome in obesity, diabetes, and NAFLD: what is your gut telling us? Curr. Hepatol. Rep. 15, 96-102. doi: 10.1007/s11901-016-0299-5
4. Agus, A., Denizot, J., Thévenot, J., Martinez-Medina, M., Massier, S., Sauvanet, P., et al. (2016). Western diet induces a shift in microbiota composition enhancing susceptibility to Adherent-Invasive E. coli infection and intestinal inflammation. Sci. Rep. 6:19032. doi: 10.1038/srep19032
5. Alard, P., Parnell, S., Manirarora, J., Kosiewicz, M., and Atay, S. (2009). Probiotics control lupus progression via induction of regulatory cells and IL-10 production. J. Immunol. 182:30.
6. Ananthakrishnan, A. N. (2015). Environmental risk factors for inflammatory bowel diseases: a review. Dig. Dis. Sci. 60, 290-298. doi: 10.1007/s10620-014-3350-9
7. Arpaia, N., Campbell, C., Fan, X., Dikiy, S., van der Veeken, J., deRoos, P., et al. (2013). Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 504, 451-455. doi: 10.1038/nature12726
8. Asquith, M., Stauffer, P., Davin, S., Mitchell, C., Lin, P., and Rosenbaum, J. T. (2016). Perturbed mucosal immunity and dysbiosis accompany clinical disease in a rat model of spondyloarthritis. Arthritis Rheumatol. doi: 10.1002/art.39681 [Epub ahead of print].
9. Atarashi, K., Tanoue, T., Oshima, K., Suda, W., Nagano, Y., Nishikawa, H., et al. (2013). Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 500, 232-236. doi: 10.1038/nature12331
10. Backhed, F., Roswall, J., Peng, Y., Feng, Q., Jia, H., Kovatcheva-Datchary, P., et al. (2015). Dynamics and stabilization of the human gut microbiome during the first year of life. Cell Host Microbe 17, 690-703. doi: 10.1016/j.chom.2015.04.004
11. Basic, M., Keubler, L. M., Buettner, M., Achard, M., Breves, G., Schröder, B., et al. (2014). Norovirus triggered microbiota-driven mucosal inflammation in interleukin 10-deficient mice. Inflamm. Bowel Dis. 20, 431-443. doi: 10.1097/01.MIB.0000441346.86827.ed
12. Bayry, J., and Radstake, T. R. (2013). Immune-mediated inflammatory diseases: progress in molecular pathogenesis and therapeutic strategies. Expert Rev. Clin. Immunol. 9, 297-299. doi: 10.1586/eci.13.10
13. Becker, C., Neurath, M. F., and Wirtz, S. (2015). The intestinal microbiota in inflammatory bowel disease. ILAR J. 56, 192-204. doi: 10.1093/ilar/ilv030
14. Belbasis, L., Bellou, V., Evangelou, E., Ioannidis, J. P. A., and Tzoulaki, I. (2015). Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses. Lancet Neurol. 14, 263-273. doi: 10.1016/S1474-4422(14)70267-4
15. Benjamin, J., Hedin, C., Koutsoumpa, A., Ng, S., McCarthy, N., Hart, A., et al. (2011). Randomised, double-blind, placebo-controlled trial of fructo-oligosaccharides in active Crohn's disease. Gut 60, 923-929. doi: 10.1136/gut.2010.232025
16. Berer, K., Mues, M., Koutrolos, M., Rasbi, Z. A., Boziki, M., Johner, C., et al. (2011). Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination - with comments. Nature 479, 538-541. doi: 10.1038/nature10554
17. Bernstein, C. N., Blanchard, J., Houston, D., and Wajda, A. (2001a). The incidence of venous thromboembolic disease among patients with IBD: a population-based study. Thromb. Haemost. 85, 430-434.
18. Bernstein, C. N., Blanchard, J., Rawsthorne, P., and Yu, N. (2001b). The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Am. J. Gastroenterol. 96, 1116-1122. doi: 10.1111/j.1572-0241.2001.03756.x
19. Bernstein, C. N., Blanchard, J., and Wajda, A. (2008). The incidence of arterial thromboembolic diseases in inflammatory bowel disease: a population-based study. Clin. Gastroenterol. Hepatol. 6, 41-45. doi: 10.1016/j.cgh.2007.09.016
20. Bernstein, C. N., Blanchard, J. F., Leslie, W., Wajda, A., and Yu, B. N. (2000). The incidence of fracture among patients with inflammatory bowel disease: a population-based cohort study. Ann. Intern. Med. 133, 795-799. doi: 10.7326/0003-4819-133-10-200011210-00012
21. Bernstein, C. N., Wajda, A., and Blanchard, J. F. (2005). The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study. Gastroenterology 129, 827-836. doi: 10.1053/j.gastro.2005.06.021
22. Blasco-baque, V., Garidou, L., Pomié, C., Escoula, Q., Loubieres, P., Le Gall-david, S., et al. (2016). Periodontitis induced by Porphyromonas gingivalis drives periodontal microbiota dysbiosis and insulin resistance via an impaired adaptive immune response. Gut doi: 10.1136/gutjnl-2015-309897 [Epub ahead of print].
23. Brown, E. M., Wlodarska, M., Willing, B. P., Vonaesch, P., Han, J., Reynolds, L. A., et al. (2015). Diet and specific microbial exposure trigger features of environmental enteropathy in a novel murine model. Nat. Commun. 6:7806. doi: 10.1038/ncomms8806
24. Brown, M. A., Laval, S. H., Brophy, S., and Calin, A. (2000). Recurrence risk modelling of the genetic susceptibility to ankylosing spondylitis. Ann. Rheum. Dis. 59, 883-886. doi: 10.1136/ard.59.11.883
25. Brown, T. M., Clark, H. W., Bailey, J. S., and Gray, C. W. (1971). A mechanistic approach to treatment of rheumatoid type arthritis naturally occurring in a gorilla. Trans. Am. Clin. Climatol. Assoc. 82, 227-247.
26. Cadwell, K., Patel, K. K., Maloney, N. S., Liu, T. C., Ng, A. C. Y., Storer, C. E., et al. (2010). Virus-plus-susceptibility gene interaction determines Crohn's disease gene Atg16L1 phenotypes in intestine. Cell 141, 1135-1145. doi: 10.1016/j.cell.2010.05.009
27. Cantarel, B. L., Waubant, E., Chehoud, C., Kuczynski, J., DeSantis, T. Z., Warrington, J., et al. (2015). Gut microbiota in multiple sclerosis. J. Investig. Med. 63, 729-734. doi: 10.1097/JIM.0000000000000192
28. Castro-Mejía, J. L., Muhammed, M. K., Kot, W., Neve, H., Franz, C. M., Hansen, L. H., et al. (2015). Optimizing protocols for extraction of bacteriophages prior to metagenomic analyses of phage communities in the human gut. Microbiome 3:64. doi: 10.1186/s40168-015-0131-4
29. Chen, J., Wright, K., Davis, J. M., Jeraldo, P., Marietta, E. V., Murray, J., et al. (2016). An expansion of rare lineage intestinal microbes characterizes rheumatoid arthritis. Genome Med. 8:43. doi: 10.1186/s13073-016-0299-7
30. Claesson, M. J., Jeffery, I. B., Conde, S., Power, S. E., O'Connor, E. M., Cusack, S., et al. (2012). Gut microbiota composition correlates with diet and health in the elderly. Nature 488, 178-184. doi: 10.1038/nature11319
31. Cohen, R., Robinson, D., Paramore, C., Fraeman, K., Renahan, K., and Bala, M. (2008). Autoimmune disease concomitance among inflammatory bowel disease patients in the United States, 2001-2002. Inflamm. Bowel Dis. 14, 738-743. doi: 10.1002/ibd.20406
32. Costello, M. E., Ciccia, F., Willner, D., Warrington, N., Robinson, P. C., Gardiner, B., et al. (2015). Brief Report: intestinal dysbiosis in ankylosing spondylitis. Arthritis Rheumatol. 67, 686-691. doi: 10.1002/art.38967
33. Cucino, C., and Sonnenberg, A. (2001). The comorbid occurrence of other diagnoses in patients with ulcerative colitis and Crohn's disease. Am. J. Gastroenterol. 96, 2107-2112. doi: 10.1111/j.1572-0241.2001.03943.x
34. Cuervo, A., Hevia, A., López, P., Suárez, A., Sánchez, B., Margolles, A., et al. (2015). Association of polyphenols from oranges and apples with specific intestinal microorganisms in systemic lupus erythematosus patients. Nutrients 7, 1301-1317. doi: 10.3390/nu7021301
35. Darfeuille-Michaud, A., Boudeau, J., Bulois, P., Neut, C., Glasser, A. L., Barnich, N., et al. (2004). High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 127, 412-421. doi: 10.1053/j.gastro.2004.04.061
36. D'Argenio, V., Casaburi, G., Precone, V., Pagliuca, C., Colicchio, R., Sarnataro, D., et al. (2016). Metagenomics reveals dysbiosis and a potentially pathogenic N. flavescens strain in duodenum of adult celiac patients. Am. J. Gastroenterol. 111, 879-890. doi: 10.1038/ajg.2016.95
37. Daulatzai, M. A. (2014). Obesity and gut's dysbiosis promote neuroinflammation, cognitive impairment, and vulnerability to Alzheimer' s disease: new directions and therapeutic implications. Mol. Genet. Med. S1:005. doi: 10.4172/1747-0862.S1-005
38. David, L. A., Materna, A. C., Friedman, J., Campos-Baptista, M. I., Blackburn, M. C., Perrotta, A., et al. (2014). Host lifestyle affects human microbiota on daily timescales. Genome Biol. 15:R89. doi: 10.1186/gb-2014-15-7-r89
39. de Meij, T., de Groot, E., Benninga, M., Budding, D., de Boer, N., van Bodegraven, A., et al. (2015). Microbiota dynamics in paediatric Crohn's disease from active disease upon achieving clinical remission. J. Crohn's Colitis S437-S438. doi: 10.1093/ecco-jcc/jju027.830
40. Dendrou, C. A., Fugger, L., and Friese, M. A. (2015). Immunopathology of multiple sclerosis. Nat. Rev. Immunol. 15, 545-558. doi: 10.1038/nri3871
41. Diaz-Gallo, L.-M., and Martin, J. (2012). Common genes in autoimmune diseases: a link between immune-mediated diseases. Expert Rev. Clin. Immunol. 8, 107-109. doi: 10.1586/eci.11.90
42. Dicksved, J., Halfvarson, J., Rosenquist, M., Jarnerot, G., Tysk, C., Apajalahti, J., et al. (2008). Molecular analysis of the gut microbiota of identical twins with Crohn's disease. ISME J. 2, 716-727. doi: 10.1038/ismej.2008.37
43. Distrutti, E., Monaldi, L., Ricci, P., Fiorucci, S., Distrutti, E., Monaldi, L., et al. (2016). Gut microbiota role in irritable bowel syndrome: new therapeutic strategies. World J. Gastroenterol. 22, 2219-2241. doi: 10.3748/wjg.v22.i7.2219
44. Dollive, S., Peterfreund, G. L., Sherrill-Mix, S., Bittinger, K., Sinha, R., Hoffmann, C., et al. (2012). A tool kit for quantifying eukaryotic rRNA gene sequences from human microbiome samples. Genome Biol. 13:R60. doi: 10.1186/gb-2012-13-7-r60
45. Duncan, S. H., Hold, G. L., Barcenilla, A., Stewart, C. S., and Flint, H. J. (2002). Roseburia intestinalis sp. nov., a novel saccharolytic, butyrate-producing bacterium from human faeces. Int. J. Syst. Evol. Microbiol. 52, 1615-1620. doi: 10.1099/ijs.0.02143-0
46. Ebringer, R., Cooke, D., Cawdell, D. R., Cowling, P., and Ebringer, A. (1977). Ankylosing spondylitis: Klebsiella and HL-A B27. Rheumatol. Rehabil. 16, 190-196. doi: 10.1093/rheumatology/16.3.190
47. Eppinga, H., Weiland, C. J. S., Bing Thio, H., van der Woude, C. J., Nijsten, T. E. C., Peppelenbosch, M. P., et al. (2015). Similar depletion of protective Faecalibacterium prausnitzii in psoriasis and inflammatory bowel disease, but not in Hidradenitis suppurativa. J. Crohn's Colitis doi: 10.1093/ecco-jcc/jjw070 [Epub ahead of print].
48. Ezendam, J., De Klerk, A., Gremmer, E. R., and Van Loveren, H. (2008). Effects of Bifidobacterium animalis administered during lactation on allergic and autoimmune responses in rodents. Clin. Exp. Immunol. 154, 424-431. doi: 10.1111/j.1365-2249.2008.03788.x
49. Ezendam, J., and van Loveren, H. (2008). Lactobacillus casei Shirota administered during lactation increases the duration of autoimmunity in rats and enhances lung inflammation in mice. Br. J. Nutr. 99, 83-90. doi: 10.1017/S0007114507803412
50. Fahlén, A., Engstrand, L., Baker, B. S., Powles, A., and Fry, L. (2012). Comparison of bacterial microbiota in skin biopsies from normal and psoriatic skin. Arch. Dermatol. Res. 304, 15-22. doi: 10.1007/s00403-011-1189-x
51. Faith, J. J., Guruge, J. L., Charbonneau, M., Subramanian, S., Seedorf, H., Goodman, A. L., et al. (2013). The long-term stability of the human gut microbiota. Science 341:1237439. doi: 10.1126/science.1237439
52. Forbes, J. D., Van Domselaar, G., and Bernstein, C. N. (2016). Microbiome survey of the inflamed and noninflamed gut at different compartments within the gastrointestinal tract of inflammatory bowel disease patients. Inflamm. Bowel Dis. 22, 817-825. doi: 10.1097/MIB.0000000000000684
53. Fry, L., and Baker, B. S. (2007). Triggering psoriasis: the role of infections and medications. Clin. Dermatol. 25, 606-615. doi: 10.1016/j.clindermatol.2007.08.015
54. Gaboriau-Routhiau, V., Rakotobe, S., Lécuyer, E., Mulder, I., Lan, A., Bridonneau, C., et al. (2009). The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity 31, 677-689. doi: 10.1016/j.immuni.2009.08.020
55. Gevers, D., Kugathasan, S., Denson, L. A., Vázquez-Baeza, Y., Van Treuren, W., Ren, B., et al. (2014). The treatment-naive microbiome in new-onset Crohn's disease. Cell Host Microbe 15, 382-392. doi: 10.1016/j.chom.2014.02.005
56. Goldblatt, F., and O'Neill, S. G. (2013). Clinical aspects of autoimmune rheumatic diseases. Lancet 382, 797-808. doi: 10.1016/S0140-6736(13)61499-3
57. Gordon, H., and Harbord, M. (2014). A patient with severe Crohn's colitis responds to faecal microbiota transplantation. J. Crohn's Colitis 8, 256-257. doi: 10.1016/j.crohns.2013.10.007
58. Guerrero, C., Tort, J., Pérez, J., Andrés, M., and Espejo, E. (2015). Rhodococcus equi infection in a patient with Crohn's disease treated with infliximab. J. Infect. 70, 689-690. doi: 10.1016/j.jinf.2014.12.008
59. Gullberg, R. (1978). Possible role of alterations of the intestinal flora in Rheumatoid Arthritis. Rheumatol. Rehabil. XVII, Suppl. 5-10. doi: 10.1093/rheumatology/XVII.suppl.5
60. Hafer, A., Krämer, S., Duncker, S., Krüger, M., Manns, M. P., and Bischoff, S. C. (2007). Effect of oral lactulose on clinical and immunohistochemical parameters in patients with inflammatory bowel disease: a pilot study. BMC Gastroenterol. 7:36. doi: 10.1186/1471-230X-7-36
61. Harbord, M., Annese, V., Vavricka, S. R., Allez, M., Barreiro-De Acosta, M., Boberg, K. M., et al. (2016). The First European evidence-based consensus on extra-intestinal manifestations in inflammatory bowel disease. J. Crohn's Colitis 10, 239-254. doi: 10.1093/ecco-jcc/jjv213
62. Hevia, A., Milani, C., López, P., Cuervo, A., Arboleya, S., Duranti, S., et al. (2014). Intestinal dysbiosis associated with systemic lupus erythematosus. MBio 5:e1548-14. doi: 10.1128/mBio.01548-14
63. Hoffmann, C., Dollive, S., Grunberg, S., Chen, J., Li, H., Wu, G. D., et al. (2013). Archaea and fungi of the human gut microbiome: correlations with diet and bacterial residents. PLoS ONE 8:e66019. doi: 10.1371/journal.pone.0066019
64. Holmøy, T., and Torkildsen, Ø. (2016). Can vitamin D reduce inflammation in relapsing-remitting multiple sclerosis? Expert Rev. Neurother. 16, 233-235. doi: 10.1586/14737175.2016.1146134
65. Huttenhower, C., Gevers, D., Knight, R., Abubucker, S., Badger, J. H., Chinwalla, A. T., et al. (2012). Structure, function and diversity of the healthy human microbiome. Nature 486, 207-214. doi: 10.1038/nature11234
66. Jarrett, F., Ducasa, G. M., Buller, D. B., and Berwick, M. (2014). The effect of oral supplementation of vitamin D3 on serum levels of vitamin D: a review. Epidemiol. Open Access 04, 2-6. doi: 10.4172/2161-1165.1000148
67. Jarukitsopa, S., Hoganson, D. D., Crowson, C. S., Sokumbi, O., Davis, M. D., Michet, C. J. Jr., et al. (2015). Epidemiology of systemic lupus erythematosus and cutaneous lupus erythematosus in a predominantly white population in the United States. Arthritis Care Res. 67, 817-828. doi: 10.1002/acr.22502
68. Jenks, K., Stebbings, S., Burton, J., Schultz, M., Herbison, P., and Highton, J. (2010). Probiotic therapy for the treatment of spondyloarthritis: a randomized controlled trial. J. Rheumatol. 37, 2118-2125. doi: 10.3899/jrheum.100193
69. Jensen, S. R., Mirsepasi-Lauridsen, H. C., Thysen, A. H., Brynskov, J., Krogfelt, K. A., Petersen, A. M., et al. (2015). Distinct inflammatory and cytopathic characteristics of Escherichia coli isolates from inflammatory bowel disease patients. Int. J. Med. Microbiol. 305, 925-936. doi: 10.1016/j.ijmm.2015.10.002
70. Jhangi, S., Gandhi, R., Glanz, B., Cook, S., Nejad, P., Ward, D., et al. (2014). Increased Archaea species and changes with therapy in gut microbiome of multiple sclerosis subjects (S24. 001). Neurology 82:S24.001.
71. Johnson, B. M., Gaudreau, M. C., Al-Gadban, M. M., Gudi, R., and Vasu, C. (2015). Impact of dietary deviation on disease progression and gut microbiome composition in lupus-prone SNF1 mice. Clin. Exp. Immunol. 181, 323-337. doi: 10.1111/cei.12609
72. Johnson, C. C., and Ownby, D. R. (2016). Allergies and asthma: do atopic disorders result from inadequate immune homeostasis arising from infant gut dysbiosis? Expert Rev. Clin. Immunol. 12, 379-388. doi: 10.1586/1744666X.2016.1139452
73. Kang, S., Denman, S. E., Morrison, M., Yu, Z., Dore, J., Leclerc, M., et al. (2010). Dysbiosis of fecal microbiota in Crohn's disease patients as revealed by a custom phylogenetic microarray. Inflamm. Bowel Dis. 16, 2034-2042. doi: 10.1002/ibd.21319
74. Keely, S., Walker, M. M., Marks, E., and Talley, N. J. (2015). Immune dysregulation in the functional GI disorders. Eur. J. Clin. Invest. 45, 1350-1359. doi: 10.1111/eci.12548
75. Kernbauer, E., Ding, Y., and Cadwell, K. (2014). An enteric virus can replace the beneficial function of commensal bacteria. Nature 516, 94-98. doi: 10.1038/nature13960
76. Khan, K. J., Ullman, T. A., Ford, A. C., Abreu, M. T., Abadir, A., and Marshall, J. K. (2011). Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis. Am. J. Gastroenterol. 106, 661-673. doi: 10.1038/ajg.2011.72
77. Kloppenburg, M., Breedveld, F. C., Terwiel, J. P., Mallee, C., and Dijkmans, B. A. (1994). Minocycline in active rheumatoid arthritis. Arthritis Rheumatol. 37, 629-636. doi: 10.1002/art.1780370505
78. Knösel, T., Schewe, C., Petersen, N., Dietel, M., and Petersen, I. (2009). Prevalence of infectious pathogens in Crohn's disease. Pathol. Res. Pract. 205, 223-230. doi: 10.1016/j.prp.2008.04.018
79. Kobayashi, T., Kato, I., Nanno, M., Shida, K., Shibuya, K., Matsuoka, Y., et al. (2010). Oral administration of probiotic bacteria, Lactobacillus casei and Bifidobacterium breve, does not exacerbate neurological symptoms in experimental autoimmune encephalomyelitis. Immunopharmacol. Immunotoxicol. 32, 116-124. doi: 10.3109/08923970903200716
80. Kohashi, O., Kohashi, Y., Takahashi, H., Ozawa, A., and Shigematsu, N. (1985). Reverse effect of gram-positive bacteria vs. gram-negative bacteria on adjuvant-induced arthritis in germfree rats. Microbiol. Immunol. 29, 487-497. doi: 10.1111/j.1348-0421.1985.tb00851.x
81. Kohashi, O., Kohashi, Y., Takahashi, H., Ozawa, A., and Shigematsu, N. (1986). Suppressive effect of Escherichia coli on adjuvant-induced arthritis in germ-free ratse. Arthritis Rheum. 29, 547-553. doi: 10.1002/art.1780290413
82. Kohashi, O., Kuwata, J., Umehara, K., Uemura, F., Takahashi, T., and Ozawa, A. (1979). Susceptibility to adjuvant-induced arthritis among germfree, specific-pathogen-free, and conventional rats. Infect. Immun. 26, 791-794.
83. Kolho, K.-L., Korpela, K., Jaakkola, T., Pichai, M. V. A., Zoetendal, E. G., and Salonen, A. (2015). Fecal microbiota in pediatric inflammatory bowel disease and its relation to inflammation. Am. J. Gastroenterol. 110, 921-930. doi: 10.1038/ajg.2015.149
84. Kushkevych, V. I (2014). Etiological role of sulfate-reducing bacteria in the development of inflammatory bowel diseases and Ulcerative Colitis. Am. J. Infect. Dis. Microbiol. 2, 63-73. doi: 10.12691/ajidm-2-3-5
85. Kwon, H. K., Kim, G. C., Kim, Y., Hwang, W., Jash, A., Sahoo, A., et al. (2013). Amelioration of experimental autoimmune encephalomyelitis by probiotic mixture is mediated by a shift in T helper cell immune response. Clin. Immunol. 146, 217-227. doi: 10.1016/j.clim.2013.01.001
86. Larcombe, S., Hutton, M. L., and Lyras, D. (2016). Involvement of bacteria other than clostridium difficile in antibiotic-associated diarrhoea. Trends Microbiol. 24, 463-476. doi: 10.1016/j.tim.2016.02.001
87. Larsen, N., Vogensen, F. K., Van Den Berg, F. W. J., Nielsen, D. S., Andreasen, A. S., Pedersen, B. K., et al. (2010). Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS ONE 5:e9085. doi: 10.1371/journal.pone.0009085
88. Lavasani, S., Dzhambazov, B., Nouri, M., Fåk, F., Buske, S., Molin, G., et al. (2010). A novel probiotic mixture exerts a therapeutic effect on experimental autoimmune encephalomyelitis mediated by IL-10 producing regulatory T cells. PLoS ONE 5:e9009. doi: 10.1371/journal.pone.0009009
89. Lee, Y. K., Menezes, J. S., Umesaki, Y., and Mazmanian, S. K. (2011). Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. U.S.A. 108(Suppl.), 4615-4622. doi: 10.1073/pnas.1000082107
90. Lepage, P., Colombet, J., Marteau, P., Sime-Ngando, T., Dore, J., and Leclerc, M. (2008). Dysbiosis. in inflammatory bowel disease: a role for bacteriophages? Gut 57, 424-425. doi: 10.1136/gut.2007.134668
91. Lepage, P., Hösler, R., Spehlmann, M. E., Rehman, A., Zvirbliene, A., Begun, A., et al. (2011). Twin study indicates loss of interaction between microbiota and mucosa of patients with ulcerative colitis. Gastroenterology 141, 227-236. doi: 10.1053/j.gastro.2011.04.011
92. Li, G., Yang, M., Zhou, K., Zhang, L., Tian, L., Lv, S., et al. (2015). Diversity of duodenal and rectal microbiota in biopsy tissues and luminal contents in healthy volunteers. J. Microbiol. Biotechnol. 25, 1136-1145. doi: 10.4014/jmb.1412.12047
93. Lin, P., Bach, M., Asquith, M., Lee, A. Y., Akileswaran, L., Stauffer, P., et al. (2014). HLA-B27 and human β2-microglobulin affect the gut microbiota of transgenic rats. PLoS ONE 9:e105684. doi: 10.1371/journal.pone.0105684
94. Lindsay, J. O., Whelan, K., Stagg, A. J., Gobin, P., Al-Hassi, H. O., Rayment, N., et al. (2006). Clinical, microbiological, and immunological effects of fructo-oligosaccharide in patients with Crohn's disease. Gut 55, 348-355. doi: 10.1136/gut.2005.074971
95. Liu, X., Zou, Q., Zeng, B., Fang, Y., and Wei, H. (2013). Analysis of fecal Lactobacillus community structure in patients with early rheumatoid arthritis. Curr. Microbiol. 67, 170-176. doi: 10.1007/s00284-013-0338-1
96. Lopez-Siles, M., Martinez-Medina, M., Abella, C., Busquets, D., Sabat-Mir, M., Duncan, S. H., et al. (2015). Mucosa-associated Faecalibacterium prausnitzii phylotype richness is reduced in patients with inflammatory bowel disease. Appl. Environ. Microbiol. 81, 7582-7592. doi: 10.1128/AEM.02006-15
97. Lutgens, M., Vermeire, S., Van Oijen, M., Vleggaar, F., Siersema, P., van Assche, G., et al. (2015). A rule for determining risk of colorectal cancer in patients with inflammatory bowel disease. Clin. Gastroenterol. Hepatol. 13, 148.e1-154.e1. doi: 10.1016/j.cgh.2014.06.032
98. Machiels, K., Joossens, M., Sabino, J., De Preter, V., Arijs, I., Eeckhaut, V., et al. (2014). A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut 63, 1275-1283. doi: 10.1136/gutjnl-2013-304833
99. Manichanh, C., Rigottier-Gois, L., Bonnaud, E., Gloux, K., Pelletier, E., Frangeul, L., et al. (2006). Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 55, 205-211. doi: 10.1136/gut.2005.073817
100. Mansson, I., and Colldahl, H. (1965). The intestinal flora in patients with bronchial asthma and rheumatoid arthritis. Allergy 20, 94-104. doi: 10.1111/j.1398-9995.1965.tb03360.x
101. Marin-Jiminez, I., García Sánchez, V., Gisbert, J., Lázaro Pérez Calle, J., Luján, M., Gordillo Ábalos, J., et al. (2014). Prevalence of different immune mediated inflammatory diseases in patients with inflammatory bowel disease. AQUILES study. Gastroenterol. Hepatol. 37, 495-502. doi: 10.1016/S1873-9946(13)60647-9
102. Martinez-Medina, M., and Garcia-Gil, L. (2014). Escherichia coli in chronic inflammatory bowel diseases: an update on adherent invasive Escherichia coli pathogenicity. World J. Gastrointest. Pathophysiol. 5, 213-227. doi: 10.4291/wjgp.v5.i3.213
103. McInnes, I. B., and Schett, G. (2011). The pathogenesis of rheumatoid arthritis. N. Engl. J. Med. 365, 2205-2219. doi: 10.1056/NEJMra1004965
104. Metz, L. M., Li, D., Traboulsee, A., Myles, M. L., Duquette, P., Godin, J., et al. (2009). Glatiramer acetate in combination with minocycline in patients with relapsing-remitting multiple sclerosis: results of a Canadian, multicenter, double-blind, placebo-controlled trial. Mult. Scler. 15, 1183-1194. doi: 10.1177/1352458509106779
105. Mielants, H., Veys, E., Goemaere, S., Goethals, K., Cuvelier, C., and De Vos, M. (1991). Gut inflammation in the spondyloarthropathies: clinical, radiologic, biologic and genetic features in relation to the type of histology. A prospective study. J. Rheumatol. 18, 1542-1551.
106. Mima, K., Nishihara, R., Qian, Z. R., Cao, Y., Sukawa, Y., Nowak, J. A., et al. (2015). Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis. Gut doi: 10.1136/gutjnl-2015-310101 [Epub ahead of print].
107. Moayyedi, P., Surette, M. G., Kim, P. T., Libertucci, J., Wolfe, M., Onischi, C., et al. (2015). Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial. Gastroenterology 149, 102-109. doi: 10.1053/j.gastro.2015.04.001
108. Mok, C., and Lau, C. (2003). Pathogenesis of systemic lupus erythematosus. J. Clin. Pathol. 56, 481-490. doi: 10.1136/jcp.56.7.481
109. Mokili, J. L., Rohwer, F., and Dutilh, B. E. (2012). Metagenomics and future perspectives in virus discovery. Curr. Opin. Virol. 2, 63-77. doi: 10.1016/j.coviro.2011.12.004
110. Mondot, S., De Wouters, T., Doré, J., and Lepage, P. (2013). The human gut microbiome and its dysfunctions. Dig. Dis. 31, 278-285. doi: 10.1159/000354678
111. Montoya, J., Matta, N. B., Suchon, P., Guzian, M. C., Lambert, N. C., Mattei, J. P., et al. (2016). Patients with ankylosing spondylitis have been breast fed less often than healthy controls: a case-control retrospective study. Ann. Rheum. Dis. 75, 879-882. doi: 10.1136/annrheumdis-2015-208187
112. Morgan, X. C., Tickle, T. L., Sokol, H., Gevers, D., Devaney, K. L., Ward, D. V., et al. (2012). Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol. 13:R79. doi: 10.1186/gb-2012-13-9-r79
113. Mowry, E., Waubant, E., Chehoud, C., DeSantis, T., Kuczynski, J., and Warrington, J. (2012). Gut bacterial populations in multiple sclerosis and in health (P05.106). Neurology 78:P05.106. doi: 10.1212/WNL.78.1_MeetingAbstracts.P05.106
114. Mucida, D., Park, Y., Kim, G., Turovskaya, O., Scott, I., Kronenberg, M., et al. (2007). Reciprocal Th17 and regulatory T cell differentiation mediated by retinoic acid. Science 317, 256-260. doi: 10.1126/science.1140114
115. Mukhopadhya, I., Hansen, R., Meharg, C., Thomson, J. M., Russell, R. K., Berry, S. H., et al. (2014). The fungal microbiota of de-novo paediatric inflammatory bowel disease. Microbes Infect. 17, 304-310. doi: 10.1016/j.micinf.2014.12.001
116. Naftali, T., Reshef, L., Kovacs, A., Porat, R., Amir, I., Konikoff, F. M., et al. (2016). Distinct microbiotas are associated with ileum-restricted and colon-involving Crohn's disease. Inflamm. Bowel Dis. 22, 293-302. doi: 10.1097/MIB.0000000000000662
117. Nagao-Kitamoto, H., Shreiner, A. B., Gillilland, M. G., Kitamoto, S., Ishii, C., Hirayama, A., et al. (2016). Functional characterization of inflammatory bowel disease-associated gut dysbiosis in gnotobiotic mice. CMGH Cell. Mol. Gastroenterol. Hepatol. 2, 468-481. doi: 10.1016/j.jcmgh.2016.02.003
118. Nair, R. P., Stuart, P. E., Nistor, I., Hiremagalore, R., Chia, N. V. C., Jenisch, S., et al. (2006). Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene. Am. J. Hum. Genet. 7878, 827-851. doi: 10.1086/503821
119. Nichols, F. C., Housley, W. J., O'Conor, C. A., Manning, T., Wu, S., and Clark, R. B. (2009). Unique lipids from a common human bacterium represent a new class of Toll-like receptor 2 ligands capable of enhancing autoimmunity. Am. J. Pathol. 175, 2430-2438. doi: 10.2353/ajpath.2009.090544
120. Norman, J. M., Handley, S. A., Parkes, M., Virgin, H. W., Norman, J. M., Handley, S. A., et al. (2015). Disease-specific alterations in the enteric virome in article disease-specific alterations in the enteric virome in inflammatory bowel disease. Cell 160, 447-460. doi: 10.1016/j.cell.2015.01.002
121. Ochoa-Repáraz, J., Mielcarz, D. W., Ditrio, L. E., Burroughs, A. R., Foureau, D. M., Haque-Begum, S., et al. (2009). Role of gut commensal microflora in the development of experimental autoimmune encephalomyelitis. J. Immunol. 183, 6041-6050. doi: 10.4049/jimmunol.0900747
122. Ochoa-Repáraz, J., Mielcarz, D. W., Haque-Begum, S., and Kasper, L. H. (2010a). Induction of a regulatory B cell population in experimental allergic encephalomyelitis by alteration of the gut commensal microflora. Gut Microbes 1, 103-108. doi: 10.4161/gmic.1.2.11515
123. Ochoa-Repáraz, J., Mielcarz, D. W., Wang, Y., Begum-Haque, S., Dasgupta, S., Kasper, D. L., et al. (2010b). A polysaccharide from the human commensal Bacteroides fragilis protects against CNS demyelinating disease. Mucosal Immunol. 3, 487-495. doi: 10.1038/mi.2010.29
124. O'Dell, J. R., Blakely, K. W., Mallek, J. A., Eckhoff, P. J., Leff, R. D., Wees, S. J., et al. (2001). Treatment of early seropositive rheumatoid arthritis: a two year, double blind comparison of minocycline and hydroxychloroquine. Arthritis Rheum. 44, 2235-2241. doi: 10.1002/1529-0131(200110)44:10<2235::AID-ART385>3.0.CO;2-A
125. O'Dell, J. R., Haire, C. E., Palmer, W., Drymalski, W., Wees, S., Blakely, K., et al. (1997). Treatment of early rheumatoid arthritis with minocycline or placebo: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 40, 842-848. doi: 10.1002/art.1780400510
126. Ogrendik, M. (2007a). Effects of clarithromycin in patients with active rheumatoid arthritis. Curr. Med. Res. Opin. 23, 515-522. doi: 10.1185/030079906X167642
127. Ogrendik, M. (2007b). Levofloxacin treatment in patients with rheumatoid arthritis receiving methotrexate. South Med. J. 100, 135-139. doi: 10.1097/01.smj.0000254190.54327.3b
128. Ogrendik, M. (2009). Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: a 3-month, randomized, double-blind, placebo-controlled trial. Clin. Ther. 31, 1754-1764. doi: 10.1016/j.clinthera.2009.08.014
129. Ogrendik, M., and Karagoz, N. (2011). Treatment of rheumatoid arthritis with roxithromycin: a randomized trial. Postgrad. Med. 123, 220-227. doi: 10.3810/pgm.2011.09.2478
130. Ott, S. J., Kuhbacher, T., Musfeldt, M., Rosenstiel, P., Hellmig, S., Rehman, A., et al. (2008). Fungi and inflammatory bowel diseases: alterations of composition and diversity. Scand. J. Gastroenterol. 43, 831-841. doi: 10.1080/00365520801935434
131. Parkes, M., Cortes, A., van Heel, D. A., and Brown, M. A. (2013). Genetic insights into common pathways and complex relationships among immune-mediated diseases. Nat. Rev. Genet. 14, 661-673. doi: 10.1038/nrg3502
132. Petersen, A. M., Halkjær, S. I., and Gluud, L. L. (2015). Intestinal colonization with phylogenetic group B2 Escherichia coli related to inflammatory bowel disease: a systematic review and meta-analysis. Scand. J. Gastroenterol. 50, 1199-1207. doi: 10.3109/00365521.2015.1028993
133. Prey, S., Paul, C., Bronsard, V., Puzenat, E., Gourraud, P. A., Aractingi, S., et al. (2010). Assessment of risk of psoriatic arthritis in patients with plaque psoriasis: a systematic review of the literature. J. Eur. Acad. Dermatol. Venereol. 24, 31-35. doi: 10.1111/j.1468-3083.2009.03565.x
134. Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., et al. (2010). A human gut microbial gene catalogue established by metagenomic sequencing: commentary. Inflamm. Bowel Dis. Monit. 11:28. doi: 10.1038/nature08821
135. Qiu, X., Zhang, M., Yang, X., Hong, N., and Yu, C. (2013). Faecalibacterium prausnitzii upregulates regulatory T cells and anti-inflammatory cytokines in treating TNBS-induced colitis. J. Crohn's Colitis 7, e558-e568. doi: 10.1016/j.crohns.2013.04.002
136. Quera, R., Espinoza, R., Estay, C., and Rivera, D. (2014). Bacteremia as an adverse event of fecal microbiota transplantation in a patient with Crohn's disease and recurrent Clostridium difficile infection. J. Crohns. Colitis 8, 252-253. doi: 10.1016/j.crohns.2013.10.002
137. Rath, H. C., Herfarth, H. H., Ikeda, J. S., Grenther, W. B., Hamm, T. E., Balish, E., et al. (1996). Normal luminal bacteria, especially bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human B2 microglobulin transgenic rats. J. Clin. Invest. 98, 945-953. doi: 10.1172/JCI118878
138. Rehakova, Z., Capkova, J., Stepankova, R., Sinkora, J., Louzecka, A., Ivanyi, P., et al. (2000). Germ-free mice do not develop ankylosing enthesopathy, a spontaneous joint disease. Hum. Immunol. 61, 555-558. doi: 10.1016/S0198-8859(00)00122-1
139. Rehaume, L. M., Mondot, S., Aguirre De Cárcer, D., Velasco, J., Benham, H., Hasnain, S. Z., et al. (2014). ZAP-70 genotype disrupts the relationship between microbiota and host, leading to spondyloarthritis and ileitis in SKG mice. Arthritis Rheumatol. 66, 2780-2792. doi: 10.1002/art.38773
140. Rezende, R. M., Oliveira, R. P., Medeiros, S. R., Gomes-Santos, A. C., Alves, A. C., Loli, F. G., et al. (2013). Hsp65-producing Lactococcus lactis prevents experimental autoimmune encephalomyelitis in mice by inducing CD4+LAP+ regulatory T cells. J. Autoimmun. 40, 45-57. doi: 10.1016/j.jaut.2012.07.012
141. Rojo, D., Hevia, A., Bargiela, R., López, P., Cuervo, A., González, S., et al. (2015). Ranking the impact of human health disorders on gut metabolism: systemic lupus erythematosus and obesity as study cases. Sci. Rep. 5:8310. doi: 10.1038/srep08310
142. Round, J. L., and Mazmanian, S. K. (2010). Inducible Foxp3+ regulatory T-cell development by\na commensal bacterium of the intestinal microbiota. Proc. Natl. Acad. Sci. U.S.A. 107, 12204-12209. doi: 10.1073/pnas.0909122107
143. Russell, R. K., Ip, B., Aldhous, M. C., MacDougall, M., Drummond, H. E., Arnott, I. D. R., et al. (2009). Anti-Saccharomyces cerevisiae antibodies status is associated with oral involvement and disease severity in Crohn disease. J. Pediatr. Gastroenterol. Nutr. 48, 161-167. doi: 10.1097/MPG.0b013e318183e112
144. Ruutu, M., Thomas, G., Steck, R., Degli-Esposti, M. A., Zinkernagel, M. S., Alexander, K., et al. (2012). B-Glucan triggers spondylarthritis and Crohn's disease-like ileitis in SKG mice. Arthritis Rheum. 64, 2211-2222. doi: 10.1002/art.34423
145. Saviola, G., Abdi-Ali, L., Campostrini, L., Sacco, S., Baiardi, P., Manfredi, M., et al. (2013). Clarithromycin in rheumatoid arthritis: the addition to methotrexate and low-dose methylprednisolone induces a significant additive value - A 24-month single-blind pilot study. Rheumatol. Int. 33, 2833-2838. doi: 10.1007/s00296-013-2822-0
146. Saviola, G., Ali, L. A., Rossini, P., Campostrini, L., Coppini, A., Gori, M., et al. (2002). Clarithromycin in rheumatoid arthritis patients not responsive to disease-modifying antirheumatic drugs: an open, uncontrolled pilot study. Clin. Exp. Rheumatol. 20, 373-378.
147. Scher, J. U., Ubeda, C., Artacho, A., Attur, M., Isaac, S., Reddy, S. M., et al. (2015). Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease. Arthritis Rheumatol. 67, 128-139. doi: 10.1002/art.38892
148. Schlosstein, L., Terasaki, P., Bluestone, R., and Pearson, C. (1973). High association of an HL-a antigen, W27, with ankylosing spondylitis. N. Engl. J. Med. 288, 704-706. doi: 10.1056/NEJM197304052881403
149. Shen, J., Zuo, Z. X., and Mao, A. P. (2014). Effect of probiotics on inducing remission and maintaining therapy in ulcerative colitis, Crohn's disease, and pouchitis: meta-analysis of randomized controlled trials. Inflamm. Bowel Dis. 20, 21-35. doi: 10.1097/01.MIB.0000437495.30052.be
150. Sher, J., Sczesnak, A., Longman, R., Segata, N., Ubeda, C., Bielski, C., et al. (2013). Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. Elife 2:e01202. doi: 10.7554/eLife.01202
151. Shreiner, A. B., Kao, J. Y., and Young, V. B. (2015). The gut microbiome in health and disease. Curr. Opin. Gastroenterol. 31, 69-75. doi: 10.1053/j.gastro.2014.03.032
152. Singh, N., Gurav, A., Sivaprakasam, S., Brady, E., Padia, R., Shi, H., et al. (2014). Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity 40, 128-139. doi: 10.1016/j.immuni.2013.12.007
153. Sinkorova, Z., Capkova, J., Neiderlova, J., Stepankova, R., and Sinkora, J. (2008). Commensal intestinal bacterial strains trigger ankylosing enthesopathy of the ankle in inbred B10.BR (H-2k) male mice. Hum. Immunol. 69, 845-850. doi: 10.1016/j.humimm.2008.08.296
154. Smith, P. M., Howitt, M. R., Panikov, N., Michaud, M., Gallini, C. A., Bohlooly-y, M., et al. (2013). The microbial metabolites, short-chain fatty acids, regulate colonic T cell homeostasis. Science 341, 569-573. doi: 10.1126/science.1241165
155. Sokol, H., Leducq, V., Aschard, H., Pham, H., Jegou, S., Landman, C., et al. (2016). Fungal microbiota dysbiosis in IBD. Gut doi: 10.1136/gutjnl-2015-310746 [Epub ahead of print].
156. Sokol, H., Pigneur, B., Watterlot, L., Lakhdari, O., Bermúdez-Humarán, L. G., Gratadoux, J.-J., et al. (2008). Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Natl. Acad. Sci. U.S.A. 105, 16731-16736. doi: 10.1073/pnas.0804812105
157. Somers, E. C., Thomas, S. L., Smeeth, L., and Hall, A. J. (2006). Autoimmune diseases co-occurring within individuals and within families. Epidemiology 17, 202-217. doi: 10.1097/01.ede.0000193605.93416.df
158. Sorrentino, R. (2014). Genetics of autoimmunity: an update. Immunol. Lett. 158, 116-119. doi: 10.1016/j.imlet.2013.12.005
159. Stebbings, S., Munro, K., Simon, M. A., Tannock, G., Highton, J., Harmsen, H., et al. (2002). Comparison of the faecal microflora of patients with ankylosing spondylitis and controls using molecular methods of analysis. Rheumatology (Oxford) 41, 1395-1401. doi: 10.1093/rheumatology/41.12.1395
160. Strauss, J., Kaplan, G. G., Beck, P. L., Rioux, K., Panaccione, R., Devinney, R., et al. (2011). Invasive potential of gut mucosa-derived Fusobacterium nucleatum positively correlates with IBD status of the host. Inflamm. Bowel Dis. 17, 1971-1978. doi: 10.1002/ibd.21606
161. Svartz, N. (1948). The treatment of rheumatic polyarthritis with acid azo compounds. Rheumatism 4, 180-185.
162. Tap, J., Mondot, S., Levenez, F., Pelletier, E., Caron, C., Furet, J.-P., et al. (2009). Towards the human intestinal microbiota phylogenetic core. Environ. Microbiol. 11, 2574-2584. doi: 10.1111/j.1462-2920.2009.01982.x
163. Taurog, J. D., Richardson, J. A., Croft, J. T., Simmons, W. A., Zhou, M., Fernández-Sueiro, J. L., et al. (1994). The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J. Exp. Med. 180, 2359-2364. doi: 10.1084/jem.180.6.2359
164. Thomas, G. P., and Brown, M. A. (2010). Genetics and genomics of ankylosing spondylitis. Immunol. Rev. 233, 162-180. doi: 10.1111/j.0105-2896.2009.00852.x
165. Tilley, B. C., Alarcon, G. S., Heyse, S. P., Trentham, D. E., Neuner, R., Kaplan, D. A., et al. (1995). Minocycline in rheumatoid arthritis: a 48-week, double-blind, placebo-controlled trial. Ann. Intern. Med. 122, 81-89. doi: 10.7326/0003-4819-122-2-199501150-00001
166. Tremlett, H., Fadrosh, D., Farqui, A., Hart, J., Roalstad, S., Graves, J., et al. (2016a). Associations between immune markers and gut microbiota in pediatric multiple sclerosis and controls (S29.008). Neurology 86:S29.008.
167. Tremlett, H., Fadrosh, D., Lynch, S., Hart, K., Graves, J., Lulu, S., et al. (2015). Gut microbiome in early pediatric multiple sclerosis: a case-control study (P4.027). Neurology 84.
168. Tremlett, H., Fadrosh, D. W., Faruqi, A. A., Hart, J., Roalstad, S., Graves, J., et al. (2016b). Gut microbiota composition and relapse risk in pediatric MS: a pilot study. J. Neurol. Sci. 363, 153-157. doi: 10.1016/j.jns.2016.02.042
169. Vaahtovuo, J., Munukka, E., Korkeamaki, M., Luukkainen, R., and Toivanen, P. (2008). Fecal microbiota in early rheumatoid arthritis. J. Rheumatol. 35, 1500-1505.
170. Vaghef-Mehrabany, E., Alipour, B., Homayouni-Rad, A., Sharif, S.-K. K., Asghari-Jafarabadi, M., and Zavvari, S. (2014). Probiotic supplementation improves inflammatory status in patients with rheumatoid arthritis. Nutrition 30, 430-435. doi: 10.1016/j.nut.2013.09.007
171. Valdimarsson, H., Baker, B. S., Jonsdottir, I., Powles, A., and Fry, L. (1995). Psoriasis: a T-cell-mediated autoimmune disease induced by streptococcal superantigens? Immunol. Today 16, 145-149. doi: 10.1016/0167-5699(95)80132-4
172. van den Broek, M. F., van Bruggen, M. C., Koopman, J. P., Hazenberg, M. P., and van den Berg, W. B. (1992). Gut flora induces and maintains resistance against streptococcal cell wall-induced arthritis in F344 rats. Clin. Exp. Immunol. 88, 313-317. doi: 10.1111/j.1365-2249.1992.tb03079.x
173. van der Meulen, T. A., Harmsen, H. J. M., Bootsma, H., Spijkervet, F. K. L., Kroese, F. G. M., and Vissink, A. (2016). The microbiome-systemic diseases connection. Oral Dis. doi: 10.1111/odi.12472 [Epub ahead of print].
174. van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., et al. (2013). Duodenal infusion of donor feces for recurrent Clostridium difficile. N. Engl. J. Med. 368, 407-415. doi: 10.1056/NEJMoa1205037
175. Vanaclocha, F., Crespo-Erchiga, V., Jiménez-Puya, R., Puig, L., Sánchez-Carazo, J. L., Ferrán, M., et al. (2015). Immune-mediated inflammatory diseases and other comorbidities in patients with psoriasis: baseline characteristics of patients in the AQUILES study. Actas Dermosifiliogr. 106, 35-43. doi: 10.1016/j.ad.2014.06.003
176. Wagner, J., Maksimovic, J., Farries, G., Sim, W. H., Bishop, R. F., Cameron, D. J., et al. (2013). Bacteriophages in gut samples from pediatric Crohn's disease patients. Inflamm. Bowel Dis. 19, 1598-1608. doi: 10.1097/MIB.0b013e318292477c
177. Wang, Y., and Kasper, L. H. (2014). The role of microbiome in central nervous system disorders. Brain. Behav. Immun. 38, 1-12. doi: 10.1016/j.bbi.2013.12.015
178. Weng, X., Liu, L., Barcellos, L. F., Allison, J. E., and Herrinton, L. J. (2007). Clustering of inflammatory bowel disease with immune mediated diseases among members of a northern California-managed care organization. Am. J. Gastroenterol. 102, 1429-1435. doi: 10.1111/j.1572-0241.2007.01215.x
179. Wexler, H. M. (2007). Bacteroides: the good, the bad, and the nitty-gritty. Clin. Microbiol. Rev. 20, 593-621. doi: 10.1128/CMR.00008-07
180. Wu, H. J., Ivanov, I. I., Darce, J., Hattori, K., Shima, T., Umesaki, Y., et al. (2010). Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity 32, 815-827. doi: 10.1016/j.immuni.2010.06.001
181. Wu, X., Chen, H., and Xu, H. (2015). The genomic landscape of human immune-mediated diseases. J. Hum. Genet. 60, 675-681. doi: 10.1038/jhg.2015.99
182. Zhang, B. J., Markovic-plese, S., Lacet, B., Raus, J., Weiner, H. L., and Hailer, D. A. (1994). Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J. Exp. Med 179, 973-984. doi: 10.1084/jem.179.3.973
183. Zhang, H., Liao, X., Sparks, J. B., and Luo, X. M. (2014). Dynamics of gut microbiota in autoimmune lupus. Appl. Environ. Microbiol. 80, 7551-7560. doi: 10.1128/AEM.02676-14
184. Zhang, X., Zhang, D., Jia, H., Feng, Q., Wang, D., Liang, D., et al. (2015). The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nat. Med. 21, 895-905. doi: 10.1038/nm.3914
185. Zitomersky, N. L., Atkinson, B. J., Franklin, S. W., Mitchell, P. D., Snapper, S. B., Comstock, L. E., et al. (2013). Characterization of adherent bacteroidales from intestinal biopsies of children and young adults with inflammatory bowel disease. PLoS ONE 8:e63686. doi: 10.1371/journal.pone.0063686